John S. March
#140,212
Most Influential Person Now
John S. March's AcademicInfluence.com Rankings
Download Badge
Biology
John S. March's Degrees
- Masters Medicine University of Pennsylvania
Why Is John S. March Influential?
(Suggest an Edit or Addition)John S. March's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. (1999) (3124)
- The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. (1997) (2121)
- Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. (2008) (1249)
- Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. (2004) (1118)
- Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. (2001) (1024)
- ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. (2001) (935)
- Cognitive assessment of obsessive-compulsive disorder (1997) (872)
- Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. (2004) (628)
- 3-year follow-up of the NIMH MTA study. (2007) (625)
- Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. (1999) (606)
- Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and Applications for Primary Care Providers (2001) (562)
- National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. (2004) (561)
- The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. (2007) (530)
- Anxiety disorders in children and adolescents (1995) (503)
- Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. (2001) (453)
- The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. (2002) (449)
- Development and natural history of mood disorders (2002) (435)
- Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. (1998) (401)
- Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. (2004) (397)
- Test-retest reliability of the Multidimensional Anxiety Scale for Children. (1999) (394)
- Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). (2006) (393)
- Observed Classroom Behavior of Children with ADHD: Relationship to Gender and Comorbidity (2002) (374)
- National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. (2004) (351)
- Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. (2012) (345)
- Clinical characteristics of anxiety disordered youth. (2010) (342)
- Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I). (2010) (334)
- Transdermal nicotine effects on attention (1998) (332)
- The Multidimensional Anxiety Scale for Children (MASC). (2004) (324)
- Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. (2007) (320)
- Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods (2010) (318)
- Nicotine effects on adults with attention-deficit/hyperactivity disorder (2005) (314)
- Cognitive-behavioral psychotherapy for children and adolescents with posttraumatic stress disorder after a single-incident stressor. (1998) (311)
- Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. (1996) (287)
- Family Processes and Treatment Outcome in the MTA: Negative/Ineffective Parenting Practices in Relation to Multimodal Treatment (2000) (287)
- Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS. (2011) (286)
- Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. (2001) (284)
- Which treatment for whom for ADHD? Moderators of treatment response in the MTA. (2003) (283)
- Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. (2001) (277)
- Peer-Assessed Outcomes in the Multimodal Treatment Study of Children With Attention Deficit Hyperactivity Disorder (2005) (265)
- Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). (2006) (249)
- National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. (1997) (249)
- Anxiety as a Predictor and Outcome Variable in the Multimodal Treatment Study of Children with ADHD (MTA) (2000) (247)
- Multidimensional Anxiety Scale for Children (2012) (244)
- Parenting and Family Stress Treatment Outcomes in Attention Deficit Hyperactivity Disorder (ADHD): An Empirical Analysis in the MTA Study (2000) (238)
- Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: an open trial of a new protocol-driven treatment package. (1994) (229)
- Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). (1996) (225)
- Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. (2007) (224)
- The case for practical clinical trials in psychiatry. (2005) (219)
- Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. (2011) (217)
- OCD in Children and Adolescents: A Cognitive-Behavioral Treatment Manual (1998) (210)
- The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial. (2009) (210)
- Naturalistic follow-up of youths treated for pediatric anxiety disorders. (2014) (209)
- Development and validation of a child version of the obsessive compulsive inventory. (2010) (209)
- Psychosocial Treatment Strategies in the MTA Study: Rationale, Methods, and Critical Issues in Design and Implementation (2000) (200)
- Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trial. (2014) (197)
- Young adult outcomes in the follow‐up of the multimodal treatment study of attention‐deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression (2017) (191)
- Tics Moderate Treatment Outcome with Sertraline but not Cognitive-Behavior Therapy in Pediatric Obsessive-Compulsive Disorder (2007) (188)
- Recovery and recurrence following treatment for adolescent major depression. (2011) (187)
- Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. AACAP. (1998) (185)
- Treatment for Adolescents with Depression Study (TADS): safety results. (2006) (178)
- Comprehensive assessment of childhood Attention-Deficit Hyperactivity Disorder in the context of a multisite, multimodal clinical trial (1997) (175)
- Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA. (2001) (169)
- The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks. (2006) (168)
- Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. (2001) (168)
- Treatment for Adolescents With Depression Study (TADS): rationale, design, and methods. (2003) (166)
- Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. (2003) (154)
- Cognitive-behavioral psychotherapy for children and adolescents with OCD: a review and recommendations for treatment. (1995) (151)
- Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. (2003) (149)
- Family-based treatment of early childhood obsessive-compulsive disorder: the Pediatric Obsessive-Compulsive Disorder Treatment Study for Young Children (POTS Jr)--a randomized clinical trial. (2014) (146)
- Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. (2007) (144)
- Trajectories of change in youth anxiety during cognitive-behavior therapy. (2015) (140)
- Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes. (2009) (138)
- Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. (2001) (138)
- Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity (2017) (138)
- Posttraumatic symptomatology in children and adolescents after an industrial fire. (1997) (137)
- Assessing medication effects in the MTA study using neuropsychological outcomes. (2006) (137)
- 24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS). (2014) (137)
- The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. (2009) (130)
- Impact of childhood trauma on treatment outcome in the Treatment for Adolescents with Depression Study (TADS). (2010) (130)
- Social phobia and separation anxiety symptoms in community and clinical samples of children and adolescents. (2000) (130)
- A Randomized Controlled Trial of Venlafaxine ER Versus Placebo in Pediatric Social Anxiety Disorder (2007) (130)
- Adolescents With Depression—Reply (2004) (129)
- Predictors of parental accommodation in pediatric obsessive-compulsive disorder: findings from the Pediatric Obsessive-Compulsive Disorder Treatment Study (POTS) trial. (2011) (122)
- Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics. (2011) (122)
- Racial Differences on the Conners Teacher Rating Scale (1998) (120)
- Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders. (2005) (120)
- The Child Anxiety Impact Scale: Examining Parent- and Child-Reported Impairment in Child Anxiety Disorders (2014) (118)
- Socioeconomic status as a moderator of ADHD treatment outcomes. (2002) (116)
- Posttraumatic Stress Disorder in Youth: A Critical Review of the Cognitive and Behavioral Treatment Outcome Literature. (2004) (115)
- Suicidal events in the Treatment for Adolescents With Depression Study (TADS). (2009) (115)
- Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS). (2006) (115)
- Evaluation of a preventive intervention for child anxiety in two randomized attention-control school trials. (2011) (114)
- Obsessive-compulsive disorder in children and adolescents: a review of the past 10 years. (1996) (111)
- Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. (2006) (110)
- Social problem-solving among adolescents treated for depression. (2010) (108)
- Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents. (1997) (104)
- Diagnostic Efficiency of the Child and Parent Versions of the Multidimensional Anxiety Scale for Children (2012) (102)
- Cognitive-Behavioral Psychotherapy for Pediatric Obsessive-Compulsive Disorder (2001) (101)
- Clinical messages from the Treatment for Adolescents With Depression Study (TADS). (2009) (95)
- Sertraline in children and adolescents with social anxiety disorder: an open trial. (2001) (93)
- Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology. (2004) (88)
- Practice Parameter for the Assessment and Treatment of Children and Adolescents With Obsessive-Compulsive Disorder (2012) (87)
- Life events and post-traumatic stress: the development of a new measure for children and adolescents (1998) (87)
- Asymmetrical hemispheric control of visual-spatial attention in adults with attention deficit hyperactivity disorder. (1997) (87)
- NIMH collaborative multimodal treatment study of children with ADHD (MTA): Design, methodology, and protocol evolution (1997) (86)
- Empirically derived subtypes of adolescent depression: latent profile analysis of co-occurring symptoms in the Treatment for Adolescents with Depression Study (TADS). (2007) (84)
- Assessing Anxiety in Youth with the Multidimensional Anxiety Scale for Children (2014) (84)
- Absence of urinary opioid peptides in children with autism (2008) (83)
- Cost-effectiveness of treatments for adolescent depression: results from TADS. (2008) (83)
- Dysfunctional Attitudes Scale Perfectionism: A Predictor and Partial Mediator of Acute Treatment Outcome among Clinically Depressed Adolescents (2009) (80)
- Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study. (2002) (80)
- Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: preliminary findings. (2001) (80)
- Assessment and intervention for attention-deficit/hyperactivity disorder in the schools. Lessons from the MTA study. (1999) (80)
- Examining the Psychometric Properties of the Family Accommodation Scale-Parent-Report (FAS-PR) (2011) (79)
- Review of safety assessment methods used in pediatric psychopharmacology. (2003) (78)
- The role of readiness to change in response to treatment of adolescent depression. (2009) (78)
- Defining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale. (2013) (73)
- The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: Views based on a systematic review and meta-analysis (2015) (70)
- A Double-Blind, Placebo-Controlled Study of Atomoxetine in Young Children With ADHD (2011) (70)
- A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder. (2014) (70)
- An Exploratory Analysis of the Impact of Family Functioning on Treatment for Depression in Adolescents (2009) (70)
- Improving attention-deficit/hyperactivity disorder treatment outcomes through use of a collaborative consultation treatment service by community-based pediatricians: a cluster randomized trial. (2007) (68)
- Anxiolytics, adrenergic agents, and naltrexone. (1999) (67)
- Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial. (2009) (66)
- Predicting the Outcome of Treatment (1998) (66)
- Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) Study. (2009) (65)
- How can we improve the assessment of safety in child and adolescent psychopharmacology? (2003) (64)
- Somatic Complaints in Anxious Youth (2014) (63)
- An Effectiveness Study of a Culturally Enriched School-Based CBT Anxiety Prevention Program (2011) (63)
- The nosology of posttraumatic stress disorder (1990) (62)
- New Developments in Assessing Pediatric Anxiety Disorders (1998) (62)
- Depression, anxiety, and functional impairment in children with trichotillomania (2008) (60)
- Acute time to response in the Treatment for Adolescents with Depression Study (TADS). (2006) (59)
- Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders. (2003) (59)
- The pediatric obsessive-compulsive disorder treatment study: rationale, design, and methods. (2003) (57)
- The impact of neuropsychological functioning on treatment outcome in pediatric obsessive–compulsive disorder (2010) (56)
- Maternal and Child Expressed Emotion as Predictors of Treatment Response in Pediatric Obsessive–Compulsive Disorder (2012) (55)
- Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients. (1990) (55)
- Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable? (2006) (55)
- Parental Anxiety as a Predictor of Medication and CBT Response for Anxious Youth (2015) (55)
- The Multidimensional Anxiety Scale for Children (MASC): Confirmatory factor analysis in a pediatric ADHD sample (1999) (55)
- BENEFITS OF CHILD‐FOCUSED ANXIETY TREATMENTS FOR PARENTS AND FAMILY FUNCTIONING (2013) (53)
- The Pediatric Obsessive-Compulsive Disorder Treatment Study II: rationale, design and methods (2009) (52)
- Therapist Factors and Outcomes in CBT for Anxiety in Youth. (2013) (52)
- Nine Months of Multicomponent Behavioral Treatment for ADHD and Effectiveness of MTA Fading Procedures (2004) (50)
- Teacher Awareness of Anxiety Symptoms in Children (2006) (50)
- Psychopharmacology of pediatric posttraumatic stress disorder. (1999) (49)
- Cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: Empirical review and clinical recommendations (2015) (48)
- A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder. (2007) (48)
- Onset of alcohol or substance use disorders following treatment for adolescent depression. (2012) (47)
- The effects of anxiety on continuous performance test functioning in an ADHD clinic sample (1997) (47)
- A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder. (2014) (47)
- Child/Adolescent anxiety multimodal study: evaluating safety. (2015) (47)
- The Child and Adolescent Psychiatry Trials Network (CAPTN). (2004) (45)
- Treatment of children and adolescents. (2000) (45)
- Cognitive-behavioral treatment for pediatric posttraumatic stress disorder: Protocol and application in school and community settings (2003) (44)
- Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents. (2006) (44)
- The Dysfunctional Attitudes Scale: Psychometric Properties in Depressed Adolescents (2009) (44)
- The future of psychotherapy for mentally ill children and adolescents. (2009) (44)
- The therapeutic relationship in cognitive-behavioral therapy and pharmacotherapy for anxious youth. (2013) (42)
- A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression. (1990) (42)
- The Role of Stimulants in the Treatment of Preschool Children with Attention-Deficit Hyperactivity Disorder (2004) (40)
- Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000. (2003) (40)
- Treating Depression and Oppositional Behavior in Adolescents (2010) (39)
- Obsessive compulsive disorder in children and adolescents: The role of the school psychologist in identification, assessment, and treatment. (1994) (38)
- Predictors of Hopelessness Among Clinically Depressed Youth (2009) (38)
- Is parental report of upper respiratory infection at the onset of obsessive-compulsive disorder suggestive of pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection? (2002) (37)
- Assessment issues in treatment research of pediatric anxiety disorders: what is working, what is not working, what is missing, and what needs improvement. (1998) (36)
- The Pediatric Obsessive Compulsive Disorder Treatment Study for Young Children (POTS jr): Developmental Considerations in the Rationale, Design, and Methods. (2012) (36)
- Treatment of Attention-Deficit/Hyperactivity Disorder: Expert Consensus Guidelines (2000) (35)
- Assessment of safety and long-term outcomes of initial treatment with placebo in TADS. (2009) (35)
- Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study. (2009) (34)
- Absence of cardiovascular adverse effects of sertraline in children and adolescents. (1999) (34)
- An assessment of the adequacy of self-care by adult asthmatics (1980) (33)
- Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government. (2006) (31)
- Depressed Adolescents and Comorbid Psychiatric Disorders: Are There Differences in the Presentation of Depression? (2008) (31)
- A manual-based intervention to address clinical crises and retain patients in the Treatment of Adolescents With Depression Study (TADS). (2007) (31)
- AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology. (2004) (30)
- Ethnic differences among adolescents beginning treatment for depression. (2010) (28)
- Comorbidity of Childhood and Adolescent Anxiety Disorders (2004) (28)
- Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy. (2008) (28)
- Response to Commentary on the Multimodal Treatment Study of ADHD (MTA): Mining the Meaning of the MTA (2002) (27)
- Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: Findings from a patient, parent and physician perspective using items from the pediatric adverse event rating scale (PAERS) (2008) (27)
- Manualized cognitive-behavioral psychotherapy for obsessive-compulsive disorder in childhood: A preliminary single case study☆ (1995) (26)
- Findings From the Treatment for Adolescents with Depression Study (TADS): What Have We Learned? What Do We Need to Know? (2009) (26)
- An open-label safety and pharmacokinetics study of duloxetine in pediatric patients with major depression. (2012) (24)
- Ethnic Differences in Attributions and Treatment Expectancies for Adolescent Depression. (2008) (24)
- Are increased weight and appetite useful indicators of depression in children and adolescents? (2012) (24)
- Anxiety Disorders in Caucasian and African American Children: A Comparison of Clinical Characteristics, Treatment Process Variables, and Treatment Outcomes (2015) (24)
- Does multimodal treatment of ADHD decrease other diagnoses? (2005) (24)
- What Have We Learned about Trial Design From NIMH-Funded Pragmatic Trials? (2010) (24)
- Factors associated with recruitment and screening in the Treatment for Adolescents With Depression Study (TADS). (2007) (23)
- Fluoxetine and fluvoxamine in PTSD. (1992) (23)
- Does Homework “Matter” in Cognitive Behavioral Therapy for Adolescent Depression? (2012) (23)
- Do subtle neurological impairments predict treatment resistance to clomipramine in children and adolescents with obsessive-compulsive disorder? (1990) (23)
- The ethical use of placebo in clinical trials involving children. (2004) (23)
- The evidence-based pharmacological treatment of paediatric ADHD. (2012) (23)
- Acute stress disorder in youth: a multivariate prediction model (2003) (23)
- A probabilistic and individualized approach for predicting treatment gains: an extension and application to anxiety disordered youth. (2014) (22)
- AACAP 2005 Research Forum: speeding the adoption of evidence-based practice in pediatric psychiatry. (2007) (22)
- Using and teaching evidence-based medicine: the Duke University child and adolescent psychiatry model. (2005) (22)
- SSRI-induced mania. (1996) (21)
- Behavioral avoidance test for childhood obsessive-compulsive disorder: a home-based observation. (2003) (21)
- Service Use and Costs of Care for Depressed Adolescents: Who Uses and Who Pays? (2009) (20)
- Treatment of pediatric obsessive-compulsive disorder: A case example of intensive cognitive-behavioral therapy involving exposure and ritual prevention (2001) (19)
- Factor Structure and Psychometric Properties of the Children's Negative Cognitive Error Questionnaire with a Clinically Depressed Adolescent Sample (2009) (18)
- The child and adolescent psychiatry trials network (CAPTN): infrastructure development and lessons learned (2009) (18)
- Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution. (2002) (18)
- Advances in the Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder (2007) (17)
- Editorial: Developmental neuroscience comes of age. (2011) (17)
- Obsessive-Compulsive Disorder in Childhood and Adolescence: Description and Treatment (2007) (17)
- Combining medication and psychosocial treatments: an evidence-based medicine approach (2002) (17)
- Looking to the future of research in pediatric anxiety disorders (2011) (16)
- Pharmacotherapy for anxiety disorders in children and adolescents: an evidence-based medicine review. (2007) (16)
- Pharmacotherapy of Obsessive-Compulsive Disorder (1995) (15)
- Neuropsychiatry of obsessive-compulsive disorder in children and adolescents. (1995) (15)
- Research knowledge among the participants in the Treatment for Adolescents With Depression Study (TADS). (2007) (15)
- Cognitive Measures of Adolescent Depression: Unique or Unitary Constructs? (2009) (15)
- Adaptive treatment strategies for children and adolescents with Obsessive-Compulsive Disorder: A sequential multiple assignment randomized trial. (2018) (14)
- Predicting Anxiety Diagnoses and Severity with the CBCL-A: Improvement Relative to Other CBCL Scales? (2015) (14)
- Integrated Psychosocial and Pharmacological Treatment (2004) (13)
- Serotonin and treatment in obsessive-compulsive disorder. (1989) (12)
- Improving the methods for evaluating the safety of psychotropic medications in children and adolescents (2001) (12)
- Attention Bias Modification Training and the New Interventions Research (2010) (12)
- Benefits Exceed Risks of Newer Antidepressant Medications in Youth—Maybe (2009) (12)
- Acute and longer-term safety results from a pooled analysis of duloxetine studies for the treatment of children and adolescents with major depressive disorder. (2015) (11)
- Kundalini Yoga Meditation Versus the Relaxation Response Meditation for Treating Adults With Obsessive-Compulsive Disorder: A Randomized Clinical Trial (2019) (11)
- Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection (PANDAS): implications for clinical practice. (2004) (10)
- Extreme thinking in clinically depressed adolescents: Results from the Treatment for Adolescents with Depression Study (TADS). (2010) (10)
- Anxiety disorders in children and adolescents: Neuropsychiatry of paediatric anxiety disorders (2000) (10)
- Summary of the practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. American Academy of Child and Adolescent Psychiatry. (1998) (10)
- It Is Time to Take a Stand for Medical Research and Against Terrorism Targeting Medical Scientists (2008) (9)
- EFFECTIVE TREATMENT OF OCD?: In Reply (2006) (9)
- A multisite psychotherapy and medication trial for depressed adolescents: Background and benefits (2005) (9)
- Comparative efficacy of cognitive behavioral therapy, fluoxetine, and their combination in depressed adolescents: Initial lessons from the treatment for adolescents with depression study (2005) (9)
- The preschool ADHD Treatment Study (PATS) as the culmination of twenty years of clinical trials in pediatric psychopharmacology. (2011) (8)
- Mutations in sphingolipid metabolism genes are associated with ADHD (2020) (8)
- Drug development in pediatric psychiatry: current status, future trends (2012) (8)
- Cognitive Aspects of Obsessive Compulsive Disorder in Children (2002) (7)
- Predicting antipsychotic use in children. (2007) (7)
- Advances in paediatric neuropsychopharmacology: an overview. (2001) (7)
- Authors of TADS study reply to letter raising concerns (2005) (7)
- Parental Marital Discord and Treatment Response in Depressed Adolescents (2011) (7)
- Pharmacotherapy of childhood anxiety disorders (2002) (6)
- Pharmacotherapy of Pediatric Anxiety Disorders (1999) (6)
- OBSESSIVE COMPULSIVE COGNITIONS WORKING GROUP* (2003) (6)
- Multimodality Therapies: Methodologie Issues in Research and Practice (1994) (5)
- Banishing OCD: Psychotherapy for cognitive-behavioral obsessive-compulsive disorders. (1996) (5)
- Combining Pharmacotherapy and Psychotherapy: An Evidence-based Approach (2010) (5)
- An evidence-based medicine approach to combined treatment for ADHD in children and adolescents. (2003) (5)
- Tyrosyl Kinase Activity Is Inversely Related to Prostatic Acid Phosphatase Activity in Two Human Prostate Carcinoma Cell Lines (2003) (5)
- 77-3 A placebo-controlled trial of sertraline treatment for pediatric obsessive compulsive disorder (1997) (4)
- Still Struggling: Characteristics of Youth With OCD Who are Partial Responders to Medication Treatment (2011) (4)
- DISTINGUISHING ANXIETY DISORDERS PSYCHOMETRICALLY (1997) (4)
- Pharmacological management of treatment-resistant pediatric depression. (2005) (4)
- Treating Obsessive-Compulsive Disorder in Children and Adolescents. (2007) (4)
- Clinical practice guidelines. (2007) (3)
- with autism Absence of urinary opioid peptides in children (2008) (3)
- Sleep disturbance in PTSD. (1990) (3)
- Review: clomipramine is more effective than SSRIs for paediatric obsessive compulsive disorder (2004) (3)
- Fluoxetine-TCA interaction. (1990) (3)
- Case report: high plasma level tricyclic antidepressant therapy in children: a case report and commentary. (1993) (2)
- MANIA IN CHILDREN WITH PDD (1997) (2)
- Practical child and adolescent psychopharmacology: Obsessive–compulsive disorder (2002) (2)
- Sertraline reduced the severity of patients’ depressive symptoms in major depressive disorder (2004) (2)
- Placebo use. Author's reply (2005) (2)
- Commentary on 'Forum: use of antidepressants in children and adolescents'. (2010) (1)
- Imipramine plus cognitive behavioural therapy (CBT) was more effective than placebo plus CBT in adolescents with comorbid anxiety and depression who refused to attend school (2000) (1)
- Children and Violence (1994) (1)
- P.3.007 Safety and efficacy of venlafaxine ER in the treatment of pediatric social anxiety disorder (2004) (1)
- Pediatric Obsessive-Compulsive Disorder (2004) (1)
- Cognitive Behavioural Therapy in Obsessive‐Compulsive Disorder: State of the Art (2012) (1)
- ASSESSMENT AND INTERVENTION FOR HYPERACTIVITY DISORDER IN THE SCHOOLS ATTENTION-DEFICIT/ (1999) (1)
- CBT VERSUS SUPPORTIVE THERAPY FOR DEPRESSION (2005) (1)
- 1 Evidence-based pharmacotherapy of attention deficit hyperactivity disorder (2015) (0)
- CBT plus parental anxiety management was more effective when the child and parent(s) were anxious (1999) (0)
- Obsessive Compulsive Inventory--Child Version (2012) (0)
- Faculty of 1000 evaluation for Annual Research Review: New frontiers in developmental neuropharmacology: can long-term therapeutic effects of drugs be optimized through carefully timed early intervention? (2011) (0)
- Parental Anxiety as a Predictor of Medication and CBT Response for Anxious Youth (2014) (0)
- Adolescents with depression. Authors' reply (2004) (0)
- CBT versus supportive therapy for depression. Authors' reply (2005) (0)
- Faculty Opinions recommendation of Attention bias modification treatment: a meta-analysis toward the establishment of novel treatment for anxiety. (2011) (0)
- Research Forum: Advancing Biomarker Sciences in Pediatric Psychiatry (2011) (0)
- Perils in Psychiatric Drug Development (2010) (0)
- TADS critiques lack scientific rigor, accuracy and thus credibility (2017) (0)
- Tailoring Treatment to Parental Values: A Comment on TADS—Reply (2008) (0)
- Maternal and Child Expressed Emotion as Predictors of Treatment Response in Pediatric Obsessive–Compulsive Disorder (2011) (0)
- Cognitive Behaviour Therapy for Children and Families: Cognitive behavioural psychotherapy for obsessive compulsive disorders (2004) (0)
- In Memoriam: Elizabeth Weller, M.D. (2010) (0)
- Predicting Anxiety Diagnoses and Severity with the CBCL-A: Improvement Relative to Other CBCL Scales? (2014) (0)
- Children's Negative Cognitive Error Questionnaire--Adaptation for Depressed Adolescents (2015) (0)
- TOWARD A RATIONAL PRESCRIBING PRACTICE (1996) (0)
- Multidimensional Anxiety Scale for Children--Portuguese Version (2019) (0)
- 189. Pediatric psychopharmacology: NIMH-sponsored multisite studies (2000) (0)
- CBT: An Important Part of Treatment (2005) (0)
- Bibliography C HILD A ND A DOLESCENT P SY C HIA T RY (2004) (0)
- Evidence-based pharmacotherapy of attention deficit hyperactivity disorder (2012) (0)
- Trastorno por estrés postraumático infantil (2006) (0)
- Cognitive Behavior Therapy for Pediatric Obsessive-Compulsive Disorder—Reply (2012) (0)
- Somatic Complaints in Anxious Youth (2013) (0)
- In Memory of Richard Todd (2008) (0)
- SPECIAL SECTION: FINDINGS FROM THE TREATMENT FOR ADOLESCENTSWITH DEPRESSIONSTUDY (TADS) (2009) (0)
- Anxiety Disorders in Caucasian and African American Children: A Comparison of Clinical Characteristics, Treatment Process Variables, and Treatment Outcomes (2014) (0)
- A Randomized Phase II Study of Pemetrexed in Combination With Cisplatin or Carboplatin as First-Line Therapy for Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (2013) (0)
- Review: a pooled long term persistence rate of 40% for childhood OCD is lower than previously expected (2005) (0)
- Report From the National Advisory Mental Health Council Workgroup on Interventions Research (2010) (0)
- Pediatric Anxiety Rating Scale (2002) (0)
- Family Accommodation Scale–-Parent Report; 12-Item Version (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With John S. March?
John S. March is affiliated with the following schools:
